Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Ivosidenib

EU orphan designation number: EU/3/16/1802   
Active ingredient: Ivosidenib
Indication: Treatment of acute myeloid leukaemia
Sponsor: QRC Consultants Ltd
Silvaco Technology Centre, Compass Point, St Ives, Cambridgeshire PE27 5JL, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/12/2016 Orphan designation EMA/OD/197/16 (2016)8702 of 12/12/2016